FDA Alerts

The FDA has approved a new migraine injection available in weekly and monthly dosing options.

The FDA has approved a new dosage strength for the combination of buprenorphine and naloxone for the maintenance treatment of opioid dependence.

The FDA has approved a new injectable fluorocycline antibiotic for the treatment of complicated intraabdominal infections.

The US Food and Drug Administration has approved a shortened version of existing brain stimulation protocol for treatment-resistant major depressive disorder.

The FDA has approved the first drug for the treatment of neurotrophic keratitis, a rare disease of the cornea.

The FDA has approved a new drug for the treatment of seizures associated with Dravet syndrome, a rare form of epilepsy.

The FDA has approved the first generic version of EpiPen and EpiPen Jr auto-injector for the treatment of allergic reactions, including anaphylaxis, in adults and children over 33 pounds.

The US Food and Drug Administration has granted approval to the first treatment in a new drug class for a nerve condition that affects about 50,000 people worldwide.

Shaina M. Willen, MD, pediatric hematologist at the Vanderbilt University Medical Center, discusses the recent FDA approval of L-glutamine oral powder for sickle cell disease - the first FDA-approved...

Shaina M. Willen, MD, pediatric hematologist at the Vanderbilt University Medical Center, discusses the recent FDA approval of L-glutamine oral powder for sickle cell disease - the first FDA-approved...